Innovative Efforts Receive Funding from NGen In Response to Canadian Supply Development Support
GUELPH, ON and MISSISSAUGA, ON, June 2, 2020 /CNW/ – Precision Biomonitoring, an industry leader in point-of-need molecular detection tools, has announced that is has received approval and funding from Next Generation Manufacturing Canada (NGen) to support manufacturing needs for the production of its TripleLockTM SARS-CoV-2 Go-Strips.
Precision Biomonitoring has secured this funding because of its ongoing efforts to contribute to the development of a Canadian supply of testing kits in response to the COVID-19 pandemic. Precision Biomonitoring is grateful to NGen for its support and is encouraged by its dedication to companies across Canada working to develop resources and tools necessary to protect public health.
The funding will enable Precision Biomonitoring to work directly with Canadian manufacturers to rapidly increase production of its SARS-CoV-2 Go-Strips, which will not only support Precision Biomonitoring, but also other Canadian biotech companies working to support the accessibility of molecular testing amidst COVID-19 and into the future.
Leveraging the manufacturing capabilities of Canadian manufacturers, Precision Biomonitoring anticipates a production rate capacity of 10,000 units per day or greater. Increased testing capacity will help provide critical testing access and capacity in communities to re-open Canadian economy by helping to create virus-free zones in the workplace to ensure safety of the workers and sustainable operations.
“Developing Canadian manufacturing is not only promising for our response efforts for COVID-19, but also provides a strong foundation as we look to expand into the growing mobile DNA applications market,” says Thomas. “This includes manufacturing our existing 35 tests for other organisms, helping to establish local sources of supply that Canadians can rely on.”
Precision Biomonitoring’s efforts alongside NGen is an addition to the collaborative relationships Precision Biomonitoring has developed with other Canadian companies and institutions in response to COVID-19, including Canadian Food Inspection Agency, Shared Value Solutions, The Research Institute of St. Joe’s (Hamilton), Sunnybrook Health Science Centre and the Canadian National Microbiology Lab.
“Advancing Canadian manufacturing enables us to leverage local capabilities to mitigate manufacturing challenges,” says John Laughlin, CTO at NGen. “We are proud to help drive these efforts that will position Canada as a world leader in manufacturing point-of-need DNA surveillance and detection tools.”
About Precision Biomonitoring
Founded in 2016 by a team of scientists from the University of Guelph’s Biodiversity Institute of Ontario, Precision Biomonitoring provides TripleLock™ onsite eDNA surveillance platform solutions that give customers earlier detection of organisms for a more rapid response. Customers are any organizations that need onsite surveillance and rapid identification of any organism in any environment. The Precision Biomonitoring team is at the forefront of technological innovations in the genomics industry. Our vision is a world where we can identify any organism on the spot, in an instant, anywhere on the planet.
NGen is the industry-led community behind Canada’s most transformative advanced manufacturing projects. NGen members come from every part of the country and cut across Canada’s manufacturing, technology, advanced research, and start-ups sectors. NGen is an objective facilitator of connections and collaboration among its members, identifying opportunities, building capabilities, and supporting advanced manufacturing decisions. NGen’s industry collaborations bring together talent, opportunity, funding, and business know-how to reduce risk and help business leaders make better choices. NGen is Canada’s Supercluster for Advanced Manufacturing, securing funding from public and private sources, including $230 million in matching dollars from the federal government’s Innovation Superclusters Initiative, to support greater private sector investment in advanced manufacturing projects. NGen seeks to add $13.5 billion dollars and 13,500 new jobs to the economy over the next 10 years by growing world-leading advanced manufacturing capabilities in Canada.
SOURCE Precision Biomonitoring
For further information: Media Contact: Meredith Adams, 416-459-7086, [email protected]
CBC Edmonton puts your COVID-19 questions to Dr. Mark Joffe of Alberta Health Services – CBC.ca
It’s been more than 16 weeks since Alberta was plunged into the COVID-19 pandemic.
Sixteen long weeks, from early spring into early summer. For many of us, that’s 16 weeks of work-from-home, school-from-home, shop-from-home — and sometimes, worry-from-home.
Restrictions are easing and there’s a semblance of a return to the way things were. But as this week’s outbreak at Edmonton’s Misericordia Community Hospital shows us, COVID-19 is still very much a threatening presence for Albertans.
Join us here at 11 a.m. MT as Edmonton News at 6 host Nancy Carlson puts your questions about COVID to Dr. Mark Joffe, an Alberta Health Services vice-president and medical director for northern Alberta.
To submit questions, tune into the broadcast on the CBC Edmonton Facebook page.
NASA remembers STS-135 mission: Plans to send the first woman to Moon in 2024 – TechGenyz
Almost nine years back America was basking in the glory of witnessing the historic landing of Atlantis on July 21 for the final time at 5 a.m. in the morning near NASA’s Kennedy Space Center. Set out on July 8, Atlantis had been the final flight for Space Shuttle Programme, on the STS-135 mission. The mission was headed by commander Christopher Ferguson, pilot Douglas Hurley along with specialists Sandra Magnus, and Rex Walheim.
STS-135, the 33rd flight was set off to carry the Raffaelo multipurpose logistics module, aiming to supply logistics, spare parts to the International Space station. The purpose was also to investigate the refueling of existing spacecraft and bring for improvisation in the upcoming systems.
In remembrance of the last mission, NASA made a post on their official website. It has already started preparing for the upcoming mission that is to take place in 2024 in order to expedite the Moon. Artemis will see the first woman on the moon and next man on the Moon by 2024.
As per the space agency, it will use innovative technologies to explore more of the lunar surface than ever before. The primary objective of the mission is to explore the moon’s surface and create sustainable missions to the Earth’s satellite by 2028.
The Artemis lunar exploration program will focus on a strategic expansion of America’s global economic impact and progressing as a leader by advancing better demonstrations and business approaches. It will conduct two missions headed by Artemis I and Artemis II.
As the name suggests, Artemis, from the Greek goddess of Moon will not merely set out for an expedition to the moon but will be observing life at other celestial bodies for a future mission to Mars.
Natural pesticide could replace antibiotics as treatment for citrus greening disease decimating US citrus industry – Genetic Literacy Project
The GLP Needs Your Help
It is easier than ever for advocacy groups to spread disinformation on pressing science issues, such as the ongoing coronavirus pandemic. No, vaccines are not harmful. Yes, the use of biotechnology, GMOs or gene editing to develop antigens for treatments including vaccines are part of the solution. To inform the public about what’s really going on, we present the facts and challenge those who don’t. We can’t do this work without your help. Please support us – a donation of as little as $10 a month helps support our vital myth-busting efforts.
Ontario's top doctor speaks as province sees 170 new COVID-19 cases, most in Windsor-Essex – CBC.ca
Sony invests $250 million in Fortnite maker Epic Games – VentureBeat
Health officials report new COVID-19 case in New Brunswick related to travel – NiagaraFallsReview.ca
Silver investment demand jumped 12% in 2019 – report – MINING.com
Iran anticipates renewed protests amid social media shutdown
Richmond BBQ spot speaks out about coronavirus rumours Vancouver Is Awesome
- Tech15 hours ago
Ninja has started streaming Fortnite on YouTube
- News23 hours ago
Canada’s public health agency warns threat of COVID-19 resurgence in Canada ‘not just hypothetical’
- News11 hours ago
New coronavirus cases, deaths continue to decline in Canada as cases top 106,400
- Health21 hours ago
Misericordia Hospital COVID-19 outbreak
- Sports12 hours ago
Montoyo urges Blue Jays to be among teams pulled together by pandemic
- Tech12 hours ago
Microsoft Teams unleashes a flood of new features for video meetings
- Politics15 hours ago
The semiconductor industry is where politics gets real for Taiwan
- Health14 hours ago
Moderna Completes Enrollment of Phase 2 Study of its mRNA Vaccine Against COVID-19 (mRNA-1273)